SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: S-1
Document Type: S-1
Date Filed: 2026-05-15
Accession Number: 0001213900-26-057939
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390026057939/ea0290954-s1_synergy.htm

Chunk 7 of 16
Word Count: 1489
Character Count: 9364

Document Content:

change in the use of proceeds and the alternate purposes for which the proceeds may be used include: ● The existence of other opportunities or the need to take advantage of changes in timing of our existing activities; ● The need or desire on our part to accelerate, increase or eliminate existing initiatives due to, among other things, changing market conditions and competitive developments; and/or ● If strategic opportunities present themselves (including acquisitions, joint ventures, licensing and other similar transactions). As a result, we cannot predict with any certainty our use of the net proceeds from this offering. Our management will retain broad discretion over the allocation of the net proceeds from this offering. Accordingly, we will have discretion in the application of the net proceeds, and investors will be relying on our judgment regarding the application of the proceeds we may receive under the ELOC Purchase Agreement. SELLING STOCKHOLDER

The Selling Stockholder may
from time to time offer and sell any or all of the shares of common stock set forth below pursuant to this prospectus. When we refer to
the Selling Stockholder in this prospectus, we refer to the entity listed in the table below, and the pledgees, donees, transferees, assignees,
successors and other permitted transferees that hold the Selling Stockholder’s interest in the shares of common stock after the
date of this prospectus.

The following table sets forth
certain information provided by or on behalf of the Selling Stockholder concerning the shares of common stock that may be offered from
time to time by the Selling Stockholder pursuant to this prospectus. The Selling Stockholder identified below may have sold, transferred
or otherwise disposed of all or a portion of their shares of common stock or other Company securities after the date on which they provided
us with information regarding such securities. Moreover, the shares of common stock identified below include only the shares being registered
for resale and may not incorporate all shares of common stock or other securities of the Company deemed to be beneficially held by the
Selling Stockholder. The number of shares of common stock beneficially owned by the Selling Stockholder is determined under rules promulgated
by the SEC.

Any changed or new information
given to us by the Selling Stockholder, including regarding the identity of, and the securities held by, the Selling Stockholder, will
be set forth in a prospectus supplement or amendments to the Registration Statement, if and when necessary. The Selling Stockholder may
sell all, some or none of the shares of common stock in this offering. See the section of this prospectus entitled “Plan of Distribution”
for more information.

Other than as described below
or elsewhere in this prospectus, the Selling Stockholder does not have any material relationship with us or any of our predecessors or
affiliates.

Name and address of Selling Stockholder Number of Shares Owned Prior to the Offering Maximum Number of Shares to be Sold Pursuant to this Prospectus Number of Shares Owned After Offering (1) Percent of Shares Owned After Offering (1)

Hudson Global Ventures, LLC (2) 170,000 101,710,000 — —

(1)	Assumes that the Selling Stockholder will sell all of the shares offered by them under this prospectus.

(2)	The principal business address for the Selling Stockholder is 1 Linden Place, Suite 210, Great Neck, NY 11021. Seth Ahdoot and Soheil Ahdoot have voting and dispositive power over the shares owned by the Selling Stockholder.

THE ELOC PURCHASE AGREEMENT

On May 8, 2026, we entered
into the ELOC Purchase Agreement with the Selling Stockholder, pursuant to which we have the right, but not the obligation, to direct
the Selling Stockholder to purchase up to $36,000,000 in ELOC Shares upon satisfaction of certain terms and conditions contained in the
ELOC Purchase Agreement. Such sales of our common stock, if any, will be subject to certain limitations, and may occur from time to time
at our sole discretion over the approximately 24-month period commencing on the date of execution of the ELOC Purchase Agreement, provided
that the Registration Statement, and any other registration statement the Company may file from time to time covering the resale by the
Selling Stockholder of ELOC Shares or Warrant Shares, is declared effective by the SEC and remains effective, and the other conditions
set forth in the ELOC Purchase Agreement are satisfied.

The Selling Stockholder has
no right to require any sales by us, but the Selling Stockholder is obligated to make purchases at our direction subject to certain conditions.
The purchase price per share is determined pursuant to the formula set forth in the ELOC Purchase Agreement and is based on discounted
market prices of our common stock. Actual sales of ELOC Shares to the Selling Stockholder from time to time will depend on a variety of
factors, including, among others, market conditions, the trading price of our common stock and determinations by us as to the appropriate
sources of funding for us and our operations. The net proceeds that we may receive under the ELOC Purchase Agreement, if any, cannot be
determined at this time, since it will depend on the frequency and prices at which we sell ELOC Shares to Selling Stockholder, our ability
to meet the conditions of the ELOC Purchase Agreement, and the other limitations, terms and conditions of the ELOC Purchase Agreement
and any impacts of the Beneficial Ownership Limitation (defined herein).

The ELOC Purchase Agreement
contains customary representations, warranties, conditions and indemnification obligations of the parties.

Purchase of ELOC Shares

Under the ELOC Purchase Agreement,
after the satisfaction of certain conditions, we have the right to deliver a Put Notice to the Selling Stockholder that directs the Selling
Stockholder to purchase an amount of ELOC Shares in an amount totaling at least $25,000 but not exceeding the lesser of (i) $2,500,000
or (ii) 200% of the average daily trading volume of the common stock during the three trading days immediately before the date of the
Put Notice.

The purchase price to be paid
by the Selling Stockholder for the ELOC Shares included in a Put Notice will be the lesser of (i) ninety-five percent (95%) of the average
of the three lowest traded prices of the Company’s common stock during the five trading days immediately preceding the date of the
Put Notice (as defined in the ELOC Purchase Agreement) and (ii) ninety-five percent (95%) of the lowest closing price of the Company’s
common stock on any trading day during the three trading days immediately following the Clearing Date (as defined in the ELOC Purchase
Agreement).

Consideration

As consideration for the Selling
Stockholder’s execution and delivery of the ELOC Purchase Agreement, we agreed to issue to the Selling Stockholder the Warrant to
purchase 1,540,000 shares of common stock as a commitment fee. We are registering all 1,540,000 Warrant Shares under the Registration
Statement. We also agreed to pay $20,000.00 to the Selling Stockholder’s legal counsel for the Selling Stockholder’s expenses
relating to the preparation of the ELOC Purchase Agreement.

Conditions
to Delivery of Advance Notices

Our ability to deliver Put
Notices under the ELOC Purchase Agreement is subject to the satisfaction of certain conditions, including, among other things, the following:

●	The Registration Statement, and any amendment or supplement thereto, must remain effective for the resale by the Selling Stockholder of the ELOC Shares and Warrant Shares at prevailing market prices and (i) neither the Company nor the Selling Stockholder shall have received notice that the SEC has issued or intends to issue a stop order with respect to the Registration Statement or that the SEC otherwise has suspended or withdrawn the effectiveness of the Registration Statement, either temporarily or permanently, or intends or has threatened to do so and (ii) there must not be any other suspension of the use of, or withdrawal of the effectiveness of, the Registration Statement or related prospectus.

●	The representations and warranties of the Company must be true and correct in all material respects as of the date of the ELOC Purchase Agreement and as of the date of each closing on ELOC Shares under the ELOC Purchase Agreement (except for representations and warranties specifically made as of a particular date).

●	The Company shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by the ELOC Purchase Agreement to be performed, satisfied or complied with by the Company, including but not limited to the delivery of the ELOC Shares in accordance with the ELOC Purchase Agreement.

●	There must not be a statute,
rule, regulation, executive order, decree, ruling or injunction that has been enacted, entered, promulgated or adopted by any court or
governmental authority of competent jurisdiction that prohibits or directly and materially adversely affects any of the transactions
contemplated by the ELOC Purchase Agreement, or any proceeding that may have the effect of prohibiting or materially adversely affecting
any of the transactions contemplated by the ELOC Purchase Agreement.